Patterns of somatic mutations in hepatitis B virus-associated hepatocellular carcinomas

来源 :第九届全国肝脏疾病临床学术大会 | 被引量 : 0次 | 上传用户:jimmyreagan
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background and Aim Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide.Most hepatocellular carcinomas develop in the background of the advanced liver fibrosis and cirrhosis through a stepwise accumulation of various genetic alterations from cirrhotic nodule to HCC.The patterns of somatic mutations in the liver cancer and its matched cirrhotic tissues were not fully characterized..Methods We performed whole exome sequencing on liver cancer tissues,its matched cirrhotic liver tissues and peripheral blood leukocyte (PBL) in 13 patients of hepatitis B virus-associated HCC.Diagnoses of HCC cases and the matched liver cirrhosis were histologically confirmed by two pathologists.Only HCCs with the percentage of tumor cells more than 70% were used for the analysis..Results Whole exome sequencing resulted in approximate 106 million raw reads with an average coverage of 110 × in each sample.A bioinformatics pipeline was used to analyze sequencing reads and identify somatic mutations.The prevalence of somatic mutations differed significantly among HCCs.Among 6,972 non-silent mutations (i.e.,missense,nonsense mutations,splice sites and translation start sites) identified in 13 HCC patients,we found that T∶ A > A∶ T transversion showed the highest percentage of non-silent mutations,followed by C∶ G > T∶ A transversion and C∶ G > A∶ T transversion.By comparison of somatic mutations identified in liver cancer tissues and cirrhotic tissues,we found that somatic mutations were not accumulated in genes in HBVassociated cirrhotic liver tissues.Notably,two genes (TP53 and KRTAP4-3) were shown to be significantly mutated by MutSigCV analysis,suggesting that there were evidence for driver mutations of these genes contributing to the development of liver cancer.Conclusion Our study may provide an overview of patterns of somatic mutation in hepatitis B-virus associated HCC and its precancerous lesions (i.e.,cirrhosis).
其他文献
会议
目的:观察和评价帕瑞昔布钠联合地塞米松用于埋伏牙拔除术术后镇痛的临床效果。方法:将64例择期行复杂埋伏牙拔除术的患者随机分为观察组和对照组,每组各32例.观察组在手术结束前30min静脉注射地塞米松10mg.两组均分别在手术结束即刻和术后12小时静脉注射帕瑞昔布钠40mg进行镇痛。结果:观察组术后12h、24h的VAS评分以及追加帕瑞昔布钠情况明显低于对照组(P<0.05);且观察组24小时局部肿
会议
目的:研究旨在揭示中药提取物肃毒星的体内外抗乙型肝炎病毒(HBV)作用及其相关作用机制.方法:以HepG2.2.15细胞(野生型HBV复制细胞系)和HepG2.A64细胞(恩替卡韦耐药型HBV复制细胞系)作为肃毒星抗HBV作用的体外评价模型;将携带1.3个拷贝HBV基因组信息的重组8型腺相关病毒经小鼠的尾静脉注射建立HBV小鼠体内评价模型.分别用荧光定量PCR、ELISA和免疫组化方法检测细胞HB
BACKGROUND: Treatment of chronic hepatitis C (CHC) with pegylated interferon-alpha/ribavirin is associated with wellcharacterized dermatological adverse events (AEs),which can lead to premature discon
目的:肝细胞性肝癌(Hepatocellular carcinoma,HCC)预后较差,治疗方法是以手术为主,化疗和放疗相结合的综合治疗,因伴有多药耐药性(Multiple drug resistance,MDR),使多种化疗药物疗效降低甚至无效.寻找特异靶点逆转MDR提高化疗敏感性已是HCC治疗热点.存在于高尔基氏体的聚集素(Clusterin,CLU)是一种具有多种生物学功能的异源二聚体硫酸化
目的:NF-κB为结合于免疫球蛋白κ轻链增强子上的核蛋白,由RelA(p65)、RelB、C-Rel、NF-κB1(p50)和NF-κB2(p52)等亚基组成,其中p50/p65最常见,p65与DNA结合后可直接作用于C末端转录元件而激活转录过程.静止期胞浆NF-κB与抑制蛋白I κB形成三聚体.当肝细胞受到肝炎病毒感染时,激活的NF-κB进入胞核与特定κB位点靶基因结合,发挥转录调节和介导免疫、
目的:探讨荔枝核总黄酮(TFL)对胆总管结扎(BDL)所致肝纤维化大鼠肝功能、核因子-κB(NF-κB)和Ⅲ型前胶原(PCⅢ)蛋白表达的影响.方法:以双重结扎胆总管结间剪断法造模,60只SD大鼠随机分为六组,每组10只,分别为:胆总管结扎组(BDL组),荔枝核总黄酮组(TFL小、中、大剂量组),水飞蓟宾组(SIL组),以假手术组(SO组)为阴性对照.造模后第2天TFL小、中、大剂量组和SIL组分别
目的:观察异甘草酸镁(MgIG)对大鼠肝细胞模拟缺血再灌注损伤的细胞凋亡影响及其机制.方法:分离、培养、鉴定大鼠肝细胞,将对数生长期肝细胞,随机分为模拟缺血再灌注损伤模型组和MgIG低浓度组(0.1mg/ml)、中浓度组(1mg/ml)、高浓度组(10mg/ml)预处理24h后,模拟缺氧6h、复氧4h,进行以下实验观察:①应用光镜观察细胞的形态改变;②应用四甲基偶氮唑盐(MTT)法检测MgIG对肝
目的:探讨在B超引导下经皮肝包膜下注射多次移植骨髓间充质干细胞(BMSCs)的方法及对大鼠肝损伤的治疗作用.方法:四氯化碳(CCl4)皮下注射建立肝损伤大鼠模型.首次移植:手术开腹,在肝损伤大鼠肝包膜下注入lmL含BMSCs胶原培养液(BMSCs移植组);在肝损伤大鼠和正常大鼠肝包膜下分别注入1mL不含BMSCs胶原培养液(分别为肝损伤对照组和正常对照组).第2次和第3次移植:分别在首次移植后第3